Family · Pharmaceutical analytical standards
Trazodone
An antidepressant of the SARI class (serotonin antagonist and reuptake inhibitor), developed in Italy in the 1960s and first marketed in 1972, in Italy; it was approved in the United States in 1981. This family brings together the active ingredient, pharmacopoeial impurities, labelled standards, nitrosamines and other impurities.
Did you know?It was designed starting from the 'mental pain' hypothesis, which holds that depression goes hand in hand with a lower pain threshold: an idea that came from observing patients.
No product matches your search.
EDQM standards 2
The official European Pharmacopoeia standards for this family.
Need a molecule you cannot find?
Custom synthesis of impurities, metabolites and labelled compounds, with the same characterisation level.
